The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oosterhuis, H. (1997) · Cited by 2,397
DEVELOPMENT OF THE VERTEBRATE NEUROMUSCULAR JUNCTION
Sanes, J. R., & Lichtman, J. W. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.389 · Cited by 1,532
LINDSTROM, J. M., SEYBOLD, M. E., LENNON, V. A., WHITTINGHAM, S., & DUANE, D. D. (1976) · Neurology · doi:10.1212/wnl.26.11.1054 · Cited by 1,186
Drachman, D. B. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406233302507 · Cited by 1,139
Agrin Acts via a MuSK Receptor Complex
Glass, D. J., Bowen, D. C., Stitt, T. N., Radziejewski, C., Bruno, J., Ryan, T. E., Gies, D. R., Shah, S., Mattsson, K., Burden, S. J., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81252-0 · Cited by 663
Vincent, A., & Newsom-Davis, J. (1985) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.48.12.1246 · Cited by 471
Self-citationValenzuela, D. M., Stitt, T. N., DiStefano, P. S., Rojas, E., Mattsson, K., Compton, D. L., Nunez, L., Park, J. S., Stark, J. L., Gies, D. R., et al. (1995) · Neuron · doi:10.1016/0896-6273(95)90146-9 · Cited by 417
CRIMEAN-CONGO HAEMORRHAGIC FEVER AND RIFT VALLEY FEVER IN SOUTH-EASTERN MAURITANIA
Saluzzo, J. F., Digoutte, J. P., Camicas, J. L., & Chauvancy, G. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92014-8 · Cited by 199
Myasthenia gravis: a population based epidemiological study in Cambridgeshire, England
Robertson, N. P., Deans, J., & Compston, D. A. S. (1998) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.65.4.492 · Cited by 187
RTK mutations and human syndromes: when good receptors turn bad
Robertson, S. C., Tynan, J., & Donoghue, D. J. (2000) · Trends in Genetics · doi:10.1016/s0168-9525(00)02077-1 · Cited by 168
Cited by
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
Lennon, V. A., Wingerchuk, D. M., Kryzer, T. J., Pittock, S. J., Lucchinetti, C. F., Fujihara, K., Nakashima, I., & Weinshenker, B. G. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17551-x · Cited by 3,239
Gilhus, N. E., Tzartos, S., Evoli, A., Palace, J., Burns, T. M., & Verschuuren, J. J. G. M. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0079-y · Cited by 953
Thrombospondin Type-1 Domain-Containing 7A in Idiopathic Membranous Nephropathy
Tomas, N. M., Beck, L. H., Meyer-Schwesinger, C., Seitz-Polski, B., Ma, H., Zahner, G., Dolla, G., Hoxha, E., Helmchen, U., Dabert-Gay, A.-S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409354 · Cited by 945
Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity
Meriggioli, M. N., & Sanders, D. B. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70063-8 · Cited by 894
A systematic review of population based epidemiological studies in Myasthenia Gravis
Carr, A. S., Cardwell, C. R., McCarron, P. O., & McConville, J. (2010) · BMC Neurology · doi:10.1186/1471-2377-10-46 · Cited by 756
Self-citationLifetime course of myasthenia gravis
Grob, D., Brunner, N., Namba, T., & Pagala, M. (2008) · Muscle & Nerve · doi:10.1002/mus.20950 · Cited by 733
Myasthenia gravis: past, present, and future
Conti-Fine, B. M., Milani, M., & Kaminski, H. J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29894 · Cited by 691
Autoantibodies to low‐density lipoprotein receptor–related protein 4 in myasthenia gravis
Higuchi, O., Hamuro, J., Motomura, M., & Yamanashi, Y. (2011) · Annals of Neurology · doi:10.1002/ana.22312 · Cited by 535
IgG1 antibodies to acetylcholine receptors in ‘seronegative’ myasthenia gravis†
Leite, M. I., Jacob, S., Viegas, S., Cossins, J., Clover, L., Morgan, B. P., Beeson, D., Willcox, N., & Vincent, A. (2008) · Brain · doi:10.1093/brain/awn092 · Cited by 527
Self-citationGuidelines for treatment of autoimmune neuromuscular transmission disorders
Skeie, G. O., Apostolski, S., Evoli, A., Gilhus, N. E., Illa, I., Harms, L., Hilton‐Jones, D., Melms, A., Verschuuren, J., & Horge, H. W. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03019.x · Cited by 515
Self-citationGlycosylation: mechanisms, biological functions and clinical implications
He, M., Zhou, X., & Wang, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01886-1 · Cited by 499
Myasthenia Gravis: Epidemiology, Pathophysiology and Clinical Manifestations
Dresser, L., Wlodarski, R., Rezania, K., & Soliven, B. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112235 · Cited by 475
Vincent, A., Palace, J., & Hilton-Jones, D. (2001) · The Lancet · doi:10.1016/s0140-6736(00)05186-2 · Cited by 452
Self-citationMechanisms Regulating Neuromuscular Junction Development and Function and Causes of Muscle Wasting
Tintignac, L. A., Brenner, H.-R., & Rüegg, M. A. (2015) · Physiological Reviews · doi:10.1152/physrev.00033.2014 · Cited by 422
Unravelling the pathogenesis of myasthenia gravis
Vincent, A. (2002) · Nature Reviews Immunology · doi:10.1038/nri916 · Cited by 414
Self-citationNeuromuscular manifestations of critical illness
Bolton, C. F. (2005) · Muscle & Nerve · doi:10.1002/mus.20304 · Cited by 411
Clinical aspects of MuSK antibody positive seronegative MG
Sanders, D. B., El-Salem, K., Massey, J. M., McConville, J., & Vincent, A. (2003) · Neurology · doi:10.1212/01.wnl.0000065882.63904.53 · Cited by 407
Self-citationAnti-GQ1b IgG antibody syndrome: clinical and immunological range
Odaka, M. (2001) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.70.1.50 · Cited by 388
Neuromuscular Junction Formation, Aging, and Disorders
Li, L., Xiong, W.-C., & Mei, L. (2018) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034255 · Cited by 370
The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes
Marx, A., Pfister, F., Schalke, B., Saruhan-Direskeneli, G., Melms, A., & Ströbel, P. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.03.007 · Cited by 351
Self-citationAnti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis
Pevzner, A., Schoser, B., Peters, K., Cosma, N.-C., Karakatsani, A., Schalke, B., Melms, A., & Kröger, S. (2012) · Journal of Neurology · doi:10.1007/s00415-011-6194-7 · Cited by 342
Self-citationTzartos, J. S. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.2393 · Cited by 342
New insights into the roles of agrin
Bezakova, G., & Ruegg, M. A. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1074 · Cited by 341
Muscle and neuronal nicotinic acetylcholine receptors: Structure, function and pathogenicity
Kalamida, D., Poulas, K., Avramopoulou, V., Fostieri, E., Lagoumintzis, G., Lazaridis, K., Sideri, A., Zouridakis, M., & Tzartos, S. J. (2007) · The FEBS Journal · doi:10.1111/j.1742-4658.2007.05935.x · Cited by 333
Zisimopoulou, P., Evangelakou, P., Tzartos, J., Lazaridis, K., Zouvelou, V., Mantegazza, R., Antozzi, C., Andreetta, F., Evoli, A., Deymeer, F., et al. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.12.004 · Cited by 329
Intravenous Immunoglobulin in Autoimmune Neuromuscular Diseases
Dalakas, M. C. (2004) · JAMA · doi:10.1001/jama.291.19.2367 · Cited by 329
MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4
Huijbers, M. G., Zhang, W., Klooster, R., Niks, E. H., Friese, M. B., Straasheijm, K. R., Thijssen, P. E., Vrolijk, H., Plomp, J. J., Vogels, P., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1313944110 · Cited by 297
Melzer, N., Ruck, T., Fuhr, P., Gold, R., Hohlfeld, R., Marx, A., Melms, A., Tackenberg, B., Schalke, B., Schneider-Gold, C., et al. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8045-z · Cited by 292
Self-citationIdentification of interaction domains of the prion protein with its 37-kDa/67-kDa laminin receptor
Hundt, C. (2001) · The EMBO Journal · doi:10.1093/emboj/20.21.5876 · Cited by 291
Diagnostic and clinical classification of autoimmune myasthenia gravis
Berrih-Aknin, S., Frenkian-Cuvelier, M., & Eymard, B. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.01.003 · Cited by 289
Lazaridis, K., & Tzartos, S. J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00212 · Cited by 287
Clinical evaluation and management of myasthenia gravis
Keesey, J. C. (2004) · Muscle & Nerve · doi:10.1002/mus.20030 · Cited by 285
Myasthenia gravis: an update for the clinician
Sieb, J. P. (2014) · Clinical and Experimental Immunology · doi:10.1111/cei.12217 · Cited by 283
Rituximab treatment of myasthenia gravis: A systematic review: Rituximab in Myasthenia Gravis
Tandan, R., Hehir, M. K., Waheed, W., & Howard, D. B. (2017) · Muscle & Nerve · doi:10.1002/mus.25597 · Cited by 275
Therapeutic advances of targeting receptor tyrosine kinases in cancer
Tomuleasa, C., Tigu, A.-B., Munteanu, R., Moldovan, C.-S., Kegyes, D., Onaciu, A., Gulei, D., Ghiaur, G., Einsele, H., & Croce, C. M. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01899-w · Cited by 260
Soukup, O., Winder, M., Killi, U. K., Wsol, V., Jun, D., Kuca, K., & Tobin, G. (2017) · Current Neuropharmacology · doi:10.2174/1570159x14666160607212615 · Cited by 34
Metadata
- Authors
- Hoch, W., McConville, J., Helms, S., Newsom-Davis, J., Melms, A., & Vincent, A.
- Venue
- Nature Medicine
- Published
- 2001-03
- Volume
- 7
- Issue
- 3
- Pages
- 365-368
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1568142966
- Cited by
- 1,183
- References
- 20
- FWCI
- 28.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.